Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
about
Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature reviewPharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonateMeta-analysis of colistin for the treatment of Acinetobacter baumannii infectionCombined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infectionTherapeutic options for Acinetobacter baumannii infections: an update.Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria.Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii.Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin.Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.Adjunctive intraventricular antibiotic therapy for bacterial central nervous system infections in critically ill patients with traumatic brain injury.Successful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Acinetobacter baumannii in Austria.Intrathecal and intraventricular antibiotics for postoperative Gram-negative meningitis and ventriculitis.Minocycline attenuates colistin-induced neurotoxicity via suppression of apoptosis, mitochondrial dysfunction and oxidative stress.
P2860
Q26796605-AD60A3CE-B750-46CB-B9DC-F2024F652B68Q36171581-1A8B643F-03D1-49C7-823C-42D176DA2A43Q36310173-09BB94B2-B0B0-4ED8-9B42-2C4D83869661Q36757544-BDFBD353-2D16-4727-A6C1-976BA85FBF96Q38049332-5F8D42AB-DAF3-4EA4-885F-7FD5C9DE1791Q38193538-549F238F-BD28-47CB-8B5C-CC98015083CBQ38204285-0CF08F44-9A2A-4152-966B-42D1D03072D8Q40045002-3128E209-5F3A-49B9-8A5A-B666D655443CQ40821276-CEC6B932-7C68-4BA1-93A5-067D8EEDE270Q41080179-4AB38ECE-42CF-4760-83A9-A631E154F23FQ41410314-2A70109E-4CE2-4C73-9B98-BCC15CAACBB5Q42233003-45059194-590B-499E-BFA4-C944D3BCE4DFQ42276229-55959F4C-C66E-4C93-A325-FCD124654F19Q46417226-CBA6BA08-5AE6-433E-B772-AAA139E9E657
P2860
Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intrathecal colistin for drug- ...... series and systematic review.
@en
Intrathecal colistin for drug- ...... series and systematic review.
@nl
type
label
Intrathecal colistin for drug- ...... series and systematic review.
@en
Intrathecal colistin for drug- ...... series and systematic review.
@nl
prefLabel
Intrathecal colistin for drug- ...... series and systematic review.
@en
Intrathecal colistin for drug- ...... series and systematic review.
@nl
P2093
P1476
Intrathecal colistin for drug- ...... series and systematic review.
@en
P2093
A Apisarnthanarak
T Khawcharoenporn
P304
P356
10.1111/J.1469-0691.2009.03019.X
P577
2009-08-17T00:00:00Z